These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2826458)

  • 1. Characteristics of an inhibitor of the Na+/K+ pump in human cerebrospinal fluid.
    Halperin JA; Riordan JF; Tosteson DC
    J Biol Chem; 1988 Jan; 263(2):646-51. PubMed ID: 2826458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digitalis-like properties of an inhibitor of the Na+/K+ pump in human cerebrospinal fluid.
    Halperin JA
    J Neurol Sci; 1989 Apr; 90(2):217-30. PubMed ID: 2542468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CV-1 cell recipients of the mouse ouabain resistance gene express a ouabain-insensitive Na,K-ATPase after growth in cardioactive steroids.
    Schulz JT; Cantley LC
    J Biol Chem; 1988 Jan; 263(2):624-32. PubMed ID: 2826456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of a Na+/K+ ATPase inhibitor from borderline hypertensives' plasma.
    Boschi S; Borghi C; Munarini A; Costa FV; Lu ZR; deVries D; Ambrosioni E
    Biochem Biophys Res Commun; 1990 Jun; 169(2):360-8. PubMed ID: 2162662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic factor inhibits the (Na,K)ATPase from the extracellular surface. Mechanism of inhibition.
    Carilli CT; Berne M; Cantley LC; Haupert GT
    J Biol Chem; 1985 Jan; 260(2):1027-31. PubMed ID: 2981828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of several ligands on the potassium-vanadate interaction in the inhibition of the (Na+ + K+)-ATPase and the Na+, K+ pump.
    Beaugé L; Berberian G
    Biochim Biophys Acta; 1983 Jan; 727(2):336-50. PubMed ID: 6301556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An effect of chloride on (Na+K) co-transport in human red blood cells.
    Chipperfield AR
    Nature; 1980 Jul; 286(5770):281-2. PubMed ID: 6250053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal.
    Tamura M; Lam TT; Inagami T
    Biochem Biophys Res Commun; 1987 Dec; 149(2):468-74. PubMed ID: 2827643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues.
    Zheng B; Oishi K; Shoji M; Eibl H; Berdel WE; Hajdu J; Vogler WR; Kuo JF
    Cancer Res; 1990 May; 50(10):3025-31. PubMed ID: 2159369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of cerebrospinal fluid (CSF) production by a Na+/K+ pump inhibitor extracted from human cerebrospinal fluid.
    Lorenzo AV; Taratuska A; Halperin JA
    Z Kinderchir; 1989 Dec; 44 Suppl 1():24-6. PubMed ID: 2560297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Na+-K+ pump activities of high- and low-potassium sheep red cells with internal magnesium and calcium altered by A23187.
    Fujise H; Lauf PK
    J Physiol; 1988 Nov; 405():605-14. PubMed ID: 3151371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of monovalent cations with the sodium pump of low-potassium goat erythrocytes.
    Cavieres JD; Ellory JC
    J Physiol; 1977 Sep; 271(1):289-318. PubMed ID: 144181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of canrenone with the Na+,K+ pump in human red blood cells.
    Garay RP; Diez J; Nazaret C; Dagher G; Abitbol JP
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):311-5. PubMed ID: 2991778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of a (Na+-K+)-ATPase inhibitor in extracts of tea.
    Sagnella GA; MacGregor GA
    Am J Clin Nutr; 1984 Jul; 40(1):36-41. PubMed ID: 6331148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of ion pumps from exogenous membrane-rich sources into mammalian red blood cells.
    Munzer JS; Silvius JR; Blostein R
    J Biol Chem; 1992 Mar; 267(8):5202-10. PubMed ID: 1312086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between fluid transport and in situ inhibition of Na(+)-K+ adenosine triphosphatase in corneal endothelium.
    Riley MV; Winkler BS; Peters MI; Czajkowski CA
    Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):560-7. PubMed ID: 8113007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ouabain-like activity in human cerebrospinal fluid.
    Halperín J; Schaeffer R; Galvez L; Malavé S
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6101-4. PubMed ID: 6310614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.